Fang Ni
Director of Finance/CFO en BLACK DIAMOND THERAPEUTICS, INC. .
Fortuna: 635 722 $ al 31/03/2024
Perfil
Fang Ni is currently the Chief Financial & Business Officer at Black Diamond Therapeutics, Inc. Prior to this role, Dr. Ni worked as the Director-Global Business Development & Licensing at F.
Hoffmann-La Roche Ltd.
from 2013 to 2017.
From 2017 to 2020, Dr. Ni served as a Principal at Versant Ventures (Switzerland) GmbH.
Dr. Ni also held the position of Chief Business Officer at Monte Rosa Therapeutics AG and Bright Peak Therapeutics AG.
Dr. Ni obtained a doctorate degree from Purdue University.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
14/02/2024 | 125 389 ( 0.24% ) | 635 722 $ | 31/03/2024 |
Cargos activos de Fang Ni
Empresas | Cargo | Inicio |
---|---|---|
BLACK DIAMOND THERAPEUTICS, INC. | Director of Finance/CFO | 19/11/2021 |
Antiguos cargos conocidos de Fang Ni.
Empresas | Cargo | Fin |
---|---|---|
Versant Ventures (Switzerland) GmbH | Private Equity Analyst | 01/08/2020 |
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Corporate Officer/Principal | 01/11/2017 |
Bright Peak Therapeutics AG
Bright Peak Therapeutics AG BiotechnologyHealth Technology Bright Peak Therapeutics AG engages in the development of engineered cytokines for immuno-oncology indications. The company is headquartered in Basel, Switzerland. | Corporate Officer/Principal | - |
Monte Rosa Therapeutics AG
Monte Rosa Therapeutics AG Pharmaceuticals: MajorHealth Technology Monte Rosa Therapeutics AG develops, manufactures and distributes cancer drugs that modulate protein degradation pathways. The company was founded in 2018 and is headquartered in Basel, Switzerland. | Corporate Officer/Principal | - |
Formación de Fang Ni.
Purdue University | Doctorate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
BLACK DIAMOND THERAPEUTICS, INC. | Health Technology |
Empresas privadas | 4 |
---|---|
F. Hoffmann-La Roche Ltd.
F. Hoffmann-La Roche Ltd. Pharmaceuticals: MajorHealth Technology F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland. | Health Technology |
Versant Ventures (Switzerland) GmbH | Finance |
Monte Rosa Therapeutics AG
Monte Rosa Therapeutics AG Pharmaceuticals: MajorHealth Technology Monte Rosa Therapeutics AG develops, manufactures and distributes cancer drugs that modulate protein degradation pathways. The company was founded in 2018 and is headquartered in Basel, Switzerland. | Health Technology |
Bright Peak Therapeutics AG
Bright Peak Therapeutics AG BiotechnologyHealth Technology Bright Peak Therapeutics AG engages in the development of engineered cytokines for immuno-oncology indications. The company is headquartered in Basel, Switzerland. | Health Technology |
- Bolsa de valores
- Insiders
- Fang Ni